Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.

Background: With the prevalence of and hospitalizations for gout increasing, optimizing care for patients with gout is imperative. The 2012 American College of Rheumatology gout guidelines emphasize that timely monitoring is key to achieving serum urate (SUA) goals. Few studies have examined this metric following the 2012 update, and to our knowledge, none have examined a veteran population.

Pharmacist Screening for Risk of Osteoporosis in Elderly Veterans.

Objective: To assess the effect of pharmacist screening for osteoporosis risk with increased bone mineral density (BMD) testing.

Design: Prospective, quasi-experiment.

Setting: Veterans Affairs medical center Community Living Centers (CLC), home-based primary care, and outpatient geriatric clinic.

Evaluation of osteoporosis risk assessment in veterans receiving androgen-deprivation therapy.

Objective: To identify whether veterans receiving androgen-deprivation therapy (ADT) are screened at any time by bone mass measurement.

Design: Cross-sectional study.

Setting: Veterans Administration Tennessee Valley Healthcare System (VA-TVHS).